New hope for Hard-to-Treat multiple myeloma: first human trial begins
Disease control
Recruiting now
This early-stage study tests a new drug called ISB 2001 in people with multiple myeloma that has returned or stopped responding to standard treatments. The main goals are to check the drug's safety and see if it can fight the cancer. About 200 participants will receive the drug i…
Phase: PHASE1 • Sponsor: Ichnos Sciences SA • Aim: Disease control
Last updated May 26, 2026 08:20 UTC